Christopher A. Natale

1.1k total citations
22 papers, 546 citations indexed

About

Christopher A. Natale is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Christopher A. Natale has authored 22 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Immunology. Recurrent topics in Christopher A. Natale's work include Immunotherapy and Immune Responses (8 papers), Estrogen and related hormone effects (6 papers) and Melanoma and MAPK Pathways (5 papers). Christopher A. Natale is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Estrogen and related hormone effects (6 papers) and Melanoma and MAPK Pathways (5 papers). Christopher A. Natale collaborates with scholars based in United States, Switzerland and Italy. Christopher A. Natale's co-authors include Todd W. Ridky, Ankit Dahal, Tzvete Dentchev, Junqian Zhang, Elizabeth K. Duperret, Brian C. Capell, Jinyang Li, Ben Z. Stanger, Shelley L. Berger and John T. Seykora and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and SHILAP Revista de lepidopterología.

In The Last Decade

Christopher A. Natale

18 papers receiving 536 citations

Peers

Countries citing papers authored by Christopher A. Natale

Since Specialization

Citations

This map shows the geographic impact of Christopher A. Natale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. Natale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. Natale more than expected).

Fields of papers citing papers by Christopher A. Natale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher A. Natale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. Natale. The network helps show where Christopher A. Natale may publish in the future.

Co-authorship network of co-authors of Christopher A. Natale

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher A. Natale. A scholar is included among the top collaborators of Christopher A. Natale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher A. Natale. Christopher A. Natale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	LNS8801: An Enantiomerically Pure Agonist of the G Protein–Coupled Estrogen Receptor Suitable for Clinical Development	Cancer Research Communications	Christopher A. Natale, Israel Olayide et al.	0
2	1137P Efficacy of LNS8801 in melanoma patients with prior immune-related adverse events from immune-checkpoint inhibitors	Annals of Oncology	Justine V. Cohen, Carolyn Y. Muller et al.	1
3	Ovariectomy-Induced Arterial Stiffening Differs From Vascular Aging and Is Reversed by GPER Activation	Hypertension	Bruna Visniauskas, Christopher A. Natale et al.	8
4	An In Vivo Study of LNS8801, a GPER Agonist, in a Spontaneous Melanoma‐Prone Mouse Model, TGS	Pigment Cell & Melanoma Research	Christopher A. Natale, Todd W. Ridky et al.	0
5	627 The effect of LNS8801 in combination with pembrolizumab in patients with treatment-refractory cutaneous melanoma	SHILAP Revista de lepidopterología	Jordi Rodon, Marya Chaney et al.	0
6	The GPER Agonist LNS8801 Induces Mitotic Arrest and Apoptosis in Uveal Melanoma Cells	Cancer Research Communications	Grazia Ambrosini, Christopher A. Natale et al.	10
7	LNS8801 inhibits Acute Myeloid Leukemia by Inducing the Production of Reactive Oxygen Species and Activating the Endoplasmic Reticulum Stress Pathway	Cancer Research Communications	Christopher A. Natale, J. Kevin Foskett et al.	2
8	1101P The effect of LNS8801 in combination with pembrolizumab in patients with treatment-refractory cutaneous melanoma	Annals of Oncology	Jordi Rodón, Marya Chaney et al.	3
9	Monitoring cell fate in 3D organotypic human squamous epithelial cultures	STAR Protocols	Christopher A. Natale, Todd W. Ridky et al.	1
10	The effect of LNS8801 alone and in combination with pembrolizumab in patients with metastatic uveal melanoma.	Journal of Clinical Oncology	Alexander N. Shoushtari, Marya Chaney et al.	6
11	Endogenous DOPA inhibits melanoma through suppression of CHRM1 signaling	Science Advances	Christopher A. Natale, Sung Hoon Kim et al.	14
12	Phase 1b study of the novel first-in-class G protein-coupled estrogen receptor (GPER) agonist, LNS8801, in combination with pembrolizumab in patients with immune checkpoint inhibitor (ICI)-relapsed and refractory solid malignancies and dose escalation update.	Journal of Clinical Oncology	Carolyn Y. Muller, Marya Chaney et al.	9
13	Pharmacologic Activation of the G Protein–Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma	Cellular and Molecular Gastroenterology and Hepatology	Christopher A. Natale, Jinyang Li et al.	44
14	Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade	eLife	Christopher A. Natale, Jinyang Li et al.	99
15	Sex steroids regulate skin pigmentation through nonclassical membrane-bound receptors	eLife	Christopher A. Natale, Elizabeth K. Duperret et al.	92
16	MLL1 is essential for the senescence-associated secretory phenotype	Genes & Development	Brian C. Capell, Adam Drake et al.	118
17	The integrin αv-TGFβ signaling axis is necessary for epidermal proliferation during cutaneous wound healing	Cell Cycle	Elizabeth K. Duperret, Christopher A. Natale et al.	27
18	CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma	Cancer Discovery	Andrew S. McNeal, Kevin Liu et al.	64
19	Abstract 1239: CDKN2B loss promotes progression from benign melanocytic nevus to melanoma	Cancer Research	Andrew S. McNeal, Kevin Liu et al.	0
20	Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC	Clinical Genetics	Alessandro Stella, Daniela Barana et al.	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact